C vs SPRB · P/E 16, rev $85.22B vs rev $4.9M
Citigroup Inc. (C) versus Spruce Biosciences Inc (SPRB) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported SPRB revenue for 2024-12-31 was $4.9M. Net income was -$53.0M. Revenue was down 51.3% from 2023-12-31 to 2024-12-31. SPRB currently screens at market cap $3.0M.
C currently screens at market cap $214.73B and trailing P/E 15.5. SPRB currently screens at market cap $3.0M.
Not investment advice. Open the C and SPRB stock pages for the full models.
Not investment advice.